Questions to Ask Your Doctor About Treatment Side Effects

 

The treatment regimen you and your doctor select to fight your cancer will be based on your individual needs and the type of cancer you have. You may experience some side effects or none at all. It is important to speak with your doctor or nurse before your treatment begins about what side effects you might expect and how to best handle them.

Not only can side effects cause discomfort and unpleasantness, and sometimes serious complications, they can also prevent your health care team from delivering the prescribed dose of therapy at the specific time and schedule of the treatment plan. Receiving treatments on schedule is important to achieving the best treatment outcome. For this reason, it is also important to let your doctor or nurse know about any unusual symptoms or feelings you may be experiencing.

Here is a list of suggested questions to ask your doctor about the side effects of treatment:

What possible side effects should I prepare for?

When might they start?

  • Will they get better or worse as my treatment goes along?
  • How can I prepare for them or lessen their impact?
  • Are there treatments that can help relieve the side effects?  What are they?  Do you usually recommend or prescribe them?
  • Which risks are most serious?
  • Will I require blood transfusions?  Why?
  • How can I best monitor myself for complications related to either my disease or my treatment?
Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health